The dental business spinout at Danaher (NYSE:DHR), Envista, is gearing up for a $600 million initial public offering this week. The spinout, announced in July 2018, will unite the Nobel Biocare, KaVo Kerr and Ormco dental brands under the Envista umbrella. The newly public company, which employs some 12,000 workers, is headquartered in Brea, Calif. Envista […]
Initial Public Offering (IPO)
SmileDirect Club plunges after IPO
Shares in SmileDirectClub (NSDQ:SDC) regained some of their value this morning after closing down some -28% after their public debut yesterday. Nashville, Tenn.-based SmileDirectClub makes 3D-printed clear dental aligners designed to provide an alternative to traditional braces. The company floated 58.5 million shares at $23 apiece in its $1.35 billion initial public offering yesterday, only to […]
Satsuma Pharmaceuticals registers $75m IPO
Satsuma Pharmaceuticals has registered an initial public offering, seeking to raise $75 million, according to a regulatory filing. The South San Francisco-based company is working on STS101, a nasal powder version of dihydroergotamine for migraine. It intends to use the money to fund its Phase 3 safety and efficacy clinical trials for STS101, manufacturing costs, preparation for […]
Frequency Therapeutics registers $100m IPO
Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market […]
InMode pulls down $70m with IPO
InMode (NSDQ:INMD) yesterday closed its initial public offering, saying it grossed $70 million for the radiofrequency devices it’s developing for aesthetic medical procedures. Proceeds from the flotation of 5 million shares at $14 apiece are earmarked for hiring additional sales and marketing personnel and expanding those programs and for funding R&D, working capital and general […]
Quanterix prices IPO common stock at $60m
Quanterix today announced an initial public offering of nearly 2.4 million shares of common stock at $25.25 apiece for which it expects to gross $60 million. Billerica, Mass.-based Quanterix is developing a digital approach to immunoassays to allow single molecules to be counted. Its technology is used in the therapeutic areas of oncology, neurology, cardiology, […]
InMode prices IPO at $70m
InMode this week announced an initial public offering of 5 million shares, for which it expects to gross $70 million. Lake Forest, Calif.-based InMode is developing devices that use minimally invasive radio-frequency technology for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode set the floatation at $14 per share, giving underwriters a 30-day option to […]
Livongo share prices double after upsized $356m IPO
Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]
Livongo boosts IPO to $268m midpoint
Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]
Livongo Health files for $100m IPO
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose reading […]
Mobile health dev G Medical Innovations sets terms for $17m IPO
Early-stage developer G Medical Innovations today set the terms for an upcoming initial public offering that could bring in approximately $17.3 million for the company. G Medical Innovations is developing wireless technologies and proprietary information technology and serve platforms for the healthcare market, according to its website. The company’s current products under development include a smartphone […]
